Investing
Nanobiotix’s stock soars after entering licensing, development deal with J&J’s Janssen Pharmaceutica
Shares of Nanobiotix SA NBTX, +1.57% shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a...

